Atomistic ensemble of active SHP2 phosphatase
Abstract
SHP2 phosphatase plays an important role in regulating several intracellular signaling pathways. Pathogenic mutations of SHP2 cause developmental disorders and are linked to hematological malignancies and cancer. SHP2 comprises two tandemly-arranged SH2 domains, a catalytic PTP domain, and a disordered C-terminal tail. Under physiological, non-stimulating conditions, the catalytic site of PTP is occluded by the N-SH2 domain, so that the basal activity of SHP2 is low. Whereas the autoinhibited structure of SHP2 has been known for two decades, its active, open structure still represents a conundrum. Since the oncogenic mutant SHP2E76K almost completely populates the active, open state, this mutant has been extensively studied as a model for activated SHP2. By molecular dynamics simulations and accurate explicit-solvent SAXS curve predictions, we present the heterogeneous atomistic ensemble of constitutively active SHP2E76K in solution, encompassing a set of conformational arrangements and radii of gyration in agreement with experimental SAXS data.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The pathogenic E139D mutation stabilizes a non-canonical active state of the multi-domain phosphatase SHP2
Anne E. van Vlimmeren, Ziyuan Jiang, … Neel H. Shah·Protein SciencePeer-reviewed·Nov 12, 2025
- The loops of the N-SH2 binding cleft do not serve as allosteric switch in SHP2 activation
M. Anselmi, J. S. Hub·bioRxiv·Nov 18, 2020
- Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1
Lisa Machner, Alaa Shaikhqasem, … Milton T. Stubbs·StructurePeer-reviewed·Dec 22, 2025
- An allosteric interaction controls the activation mechanism of SHP2 tyrosine phosphatase
M. Anselmi, J. S. Hub·Scientific ReportsPeer-reviewed·Oct 28, 2020
- Phosphatase SHP2 pathogenic mutations enhance activity by altering conformational sampling
Andrew Glaser, R.A.P. Padua, … Dorothee Kern·Proceedings of the National Academy of SciencesPeer-reviewed·Jan 13, 2026
- Disease-Causing Mutations Alter the Interplay Between Loop Dynamics and Catalysis in the Protein Tyrosine Phosphatases SHP-1 and SHP-2
Alfie-Louise R. Brownless, Michael Robinson, Shina Caroline Lynn Kamerlin·bioRxiv·Mar 3, 2026